Kolexia
Auperin Anne Santé publique
Auperin Anne
Santé publique
Gustave-Roussy
Villejuif, France
176 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Carcinomes Tumeurs de la tête et du cou Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Lymphomes Lymphome B Maladie de Hodgkin Tumeurs du poumon Lymphome malin non hodgkinien

Collaborateurs

Voir plus
Bourhis Jean
Bourhis Jean
Gustave-Roussy, Villejuif, France
Guigay Joel
Guigay Joel
Centre Antoine Lacassagne, Nice, France
Even Caroline
Even Caroline
Gustave-Roussy, Villejuif, France
Blanchard Pierre
Blanchard Pierre
Gustave-Roussy, Villejuif, France

Industries

Voir plus
MSD
3 collaboration(s)
Dernière en 2023
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial.
The Lancet. Healthy longevity   05 mars 2024
ELAN-UNFIT: Multicentric Randomized Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer in Elderly Unfit Patients According to Geriatric Evaluation
Essai Clinique (Merck-Serono)   07 février 2024
Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology   11 novembre 2023
A Potential Paradigm for the Robust and Systematic Prioritisation of Assets in Academic-Led, Multi-Industry Collaborative Trials in Rare Populations (Glo-BNHL)
65th ASH Annual Meeting Abstracts   02 novembre 2023
A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-Cell Non-Hodgkin Lymphoma (Glo-BNHL)
65th ASH Annual Meeting Abstracts   02 novembre 2023
940P Salvage chemotherapy after progression on nivolumab in patients with squamous cell carcinoma of the head and neck included in the phase II TOPNIVO trial
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
865P Molecular analysis of surgical margins in early oral carcinomas (OSCC)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
857O MACH-EGFR: Individual patient data (IPD) meta-analysis of anti-EGFR monoclonal antibodies (Ab) in patients (pts) with locally advanced (LA) squamous cell carcinomas of head and neck (SCCHN)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
REACH: A Phase III Randomized Trial of Avelumab-cetuximab-Radiotherapy Versus Standards of Care in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Essai Clinique (Groupe d'Oncologie Radiothérapie Tête Et Cou)   19 juin 2023
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
The Lancet. Oncology   05 juin 2023